Diletta Overi

21PUBLICATIONS
74CO-AUTHORS
Cancer diagnosisCancer cell biologyOphthalmologyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Sep 05, 2026
Gut microbiota-derived imidazole propionate promotes primary sclerosing cholangitis via p38 signalling.

|Apr 28, 2026
MARCO promotes cholangiocarcinogenesis by inducing immunosuppression and its targeting reduces tumor growth.

|Aug 05, 2025
Role of CNNM4 in the progression of cholangiocarcinoma: implications for ferroptosis and therapeutic potential.

Maria Mercado-Gómez, Naroa Goikoetxea-Usandizaga, Alvaro Eguileor Giné

|Jun 19, 2024
Oleuropein, a Component of Extra Virgin Olive Oil, Improves Liver Steatosis and Lobular Inflammation by Lipopolysaccharides-TLR4 Axis Downregulation.

Leonardo Schirone, Diletta Overi, Guido Carpino

|Mar 13, 2024
Cholangiocarcinoma Malignant Traits Are Promoted by Schwann Cells through TGFβ Signaling in a Model of Perineural Invasion.

Valerio de Franchis, Simonetta Petrungaro, Elisa Pizzichini

|Sep 27, 2023
Molecular portraits of patients with intrahepatic cholangiocarcinoma who diverge as rapid progressors or long survivors on chemotherapy.

Colm J O'Rourke, Massimiliano Salati, Colin Rae

Pageof 4

Frequent Collaborators

16 joint publications

Guido Carpino

5 joint publications

Lorenzo Nevi

3 joint publications

Rocio I R Macias

2 joint publications

Sabina Di Matteo